These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11342177

  • 1. Vesicular monoamine transporters heterologously expressed in the yeast Saccharomyces cerevisiae display high-affinity tetrabenazine binding.
    Yelin R, Schuldiner S.
    Biochim Biophys Acta; 2001 Feb 09; 1510(1-2):426-41. PubMed ID: 11342177
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells.
    Adamson CR, Emley TE, Herbig LJ, Near JA.
    Neurochem Int; 1997 Feb 09; 30(4-5):411-5. PubMed ID: 9106255
    [Abstract] [Full Text] [Related]

  • 5. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M, Weizman A, Rehavi M.
    Life Sci; 2001 Sep 28; 69(19):2311-7. PubMed ID: 11669473
    [Abstract] [Full Text] [Related]

  • 6. Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
    Erickson JD, Eiden LE, Hoffman BJ.
    Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10993-7. PubMed ID: 1438304
    [Abstract] [Full Text] [Related]

  • 7. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5166-71. PubMed ID: 8643547
    [Abstract] [Full Text] [Related]

  • 8. Expression and regulation of the bovine vesicular monoamine transporter gene.
    Krejci E, Gasnier B, Botton D, Isambert MF, Sagné C, Gagnon J, Massoulié J, Henry JP.
    FEBS Lett; 1993 Nov 29; 335(1):27-32. PubMed ID: 7902299
    [Abstract] [Full Text] [Related]

  • 9. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.
    Naudon L, Raisman-Vozari R, Edwards RH, Leroux-Nicollet I, Peter D, Liu Y, Costentin J.
    Eur J Neurosci; 1996 Apr 29; 8(4):842-6. PubMed ID: 9081637
    [Abstract] [Full Text] [Related]

  • 10. Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.
    Rehavi M, Roz N, Weizman A.
    Eur Neuropsychopharmacol; 2002 Jun 29; 12(3):261-8. PubMed ID: 12007678
    [Abstract] [Full Text] [Related]

  • 11. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
    Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B.
    J Exp Biol; 1994 Nov 29; 196():251-62. PubMed ID: 7823026
    [Abstract] [Full Text] [Related]

  • 12. Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.
    Schwartz K, Yadid G, Weizman A, Rehavi M.
    Brain Res; 2003 Mar 07; 965(1-2):174-9. PubMed ID: 12591135
    [Abstract] [Full Text] [Related]

  • 13. Structural organization of the human vesicular monoamine transporter type-2 gene and promoter analysis using the jelly fish green fluorescent protein as a reporter.
    Xu W, Liu L, Mooslehner K, Emson PC.
    Brain Res Mol Brain Res; 1997 Apr 07; 45(1):41-9. PubMed ID: 9105669
    [Abstract] [Full Text] [Related]

  • 14. Murine vesicular monoamine transporter 2: molecular cloning and genomic structure.
    Takahashi N, Uhl G.
    Brain Res Mol Brain Res; 1997 Oct 03; 49(1-2):7-14. PubMed ID: 9387858
    [Abstract] [Full Text] [Related]

  • 15. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
    Peter D, Vu T, Edwards RH.
    J Biol Chem; 1996 Feb 09; 271(6):2979-86. PubMed ID: 8621690
    [Abstract] [Full Text] [Related]

  • 16. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.
    Sievert MK, Thiriot DS, Edwards RH, Ruoho AE.
    Biochem J; 1998 Mar 01; 330 ( Pt 2)(Pt 2):959-66. PubMed ID: 9480916
    [Abstract] [Full Text] [Related]

  • 17. The vesicular monoamine transporter: from chromaffin granule to brain.
    Henry JP, Sagné C, Bedet C, Gasnier B.
    Neurochem Int; 1998 Mar 01; 32(3):227-46. PubMed ID: 9587917
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the subregional distributions of the monoamine vesicular transporter and dopamine uptake complex in the rat striatum and changes during aging.
    Leroux-Nicollet I, Costentin J.
    J Neural Transm Gen Sect; 1994 Mar 01; 97(2):93-106. PubMed ID: 7873127
    [Abstract] [Full Text] [Related]

  • 19. Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate.
    Steiner-Mordoch S, Shirvan A, Schuldiner S.
    J Biol Chem; 1996 May 31; 271(22):13048-54. PubMed ID: 8662678
    [Abstract] [Full Text] [Related]

  • 20. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
    Canney DJ, Kung MP, Kung HF.
    Nucl Med Biol; 1995 May 31; 22(4):527-35. PubMed ID: 7550031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.